The Lundquist Institute and Mayo Clinic Awarded 2.46M NIH Grant to Investigate Cellular Senescence in Trisomy 21 Lung Disease

LUNG Stock  USD 6.45  0.15  2.38%   
Roughly 60% of Pulmonx Corp's investor base is looking to short. The analysis of overall sentiment of trading Pulmonx Corp stock suggests that many investors are alarmed at this time. The current market sentiment, together with Pulmonx Corp's historical and current headlines, can help investors time the market. In addition, many technical investors use Pulmonx Corp stock news signals to limit their universe of possible portfolio assets.
  
Los Angeles, California, Oct. 21, 2024 -- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, in collaboration with Mayo Clinic, is proud to announce that Dr. Denise Al Alam and her co-Principal Investigator colleague, Dr. Christina Pabelick from the Mayo Clinic, Rochester, MN have been awarded a prestigious R01 Grant from the National Institutes of Health - National Heart, Lung, and Blood Institute . The grant, totaling 2,457,071, has

Read at finance.yahoo.com
Yahoo News
  

Pulmonx Corp Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Pulmonx Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Pulmonx Corp Fundamental Analysis

We analyze Pulmonx Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pulmonx Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pulmonx Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Target Price

Target Price Comparative Analysis

Pulmonx Corp is currently under evaluation in target price category among its peers.

Pulmonx Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pulmonx Corp stock to make a market-neutral strategy. Peer analysis of Pulmonx Corp could also be used in its relative valuation, which is a method of valuing Pulmonx Corp by comparing valuation metrics with similar companies.

Peers

Pulmonx Corp Related Equities

NPCENeuropace   3.41   
0%
72.0%
KIDSOrthopediatrics Corp   2.32   
0%
49.0%
SIBNSi Bone   2.19   
0%
46.0%
OFIXOrthofix Medical   2.09   
0%
44.0%
CNMDCONMED   1.20   
0%
25.0%
RXSTRxsight   1.03   
0%
21.0%
INGNInogen   0.83   
0%
17.0%
IRMDIradimed   0.65   
0%
13.0%
LIVNLivaNova PLC   0.04   
0%
1.0%
ITGRInteger Holdings   0.21   
4.0%
0%
SRDXSurModics   0.23   
4.0%
0%
TMCITreace Medical   0.47   
9.0%
0%
ELMDElectromed   0.90   
19.0%
0%
AXGNAxogen   1.21   
25.0%
0%
APYXApyx Medical   4.73   
100.0%
0%

Complementary Tools for Pulmonx Stock analysis

When running Pulmonx Corp's price analysis, check to measure Pulmonx Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulmonx Corp is operating at the current time. Most of Pulmonx Corp's value examination focuses on studying past and present price action to predict the probability of Pulmonx Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulmonx Corp's price. Additionally, you may evaluate how the addition of Pulmonx Corp to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk